Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 20201-20250 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT01910610
Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer
PHASE3Active, not recruiting
464 participants
Started: Oct 30, 2013 · Completed: Dec 31, 2024
1 condition2 sponsors56 locations
NCT04286217
SD-OCT Measurement of the Human Retina in Pregnancy With Pre-existing or De Novo Hypertension and Without Hypertension
N/AActive, not recruiting
155 participants
Started: Oct 30, 2013 · Completed: Dec 31, 2026
2 conditions1 sponsor0 locations
NCT03970304
CVD 37000: Immunity and Microbiome Studies At Intestinal and Systemic Sites in Ty21a Vaccinated Adults
PHASE4Active, not recruiting
87 participants
Started: Oct 24, 2013 · Completed: Aug 1, 2027
1 condition1 sponsor1 location
NCT01872260
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
PHASE1/PHASE2Active, not recruiting
255 participants
Started: Oct 22, 2013 · Completed: Dec 31, 2025
1 condition1 sponsor25 locations
NCT03909178
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum
NAActive, not recruiting
110 participants
Started: Oct 21, 2013 · Completed: Jun 30, 2030
5 conditions1 sponsor1 location
NCT01909245
Islet Cell Transplant for Type 1 Diabetes
PHASE2Active, not recruiting
10 participants
Started: Oct 16, 2013 · Completed: Oct 16, 2025
1 condition2 sponsors1 location
NCT01946204
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
PHASE3Active, not recruiting
1,207 participants
Started: Oct 14, 2013 · Completed: Dec 31, 2027
1 condition1 sponsor379 locations
NCT01950351
Hypofractionated Proton Beam Therapy for Localized Prostate Cancer
PHASE1/PHASE2Active, not recruiting
241 participants
Started: Oct 10, 2013 · Completed: Jun 1, 2028
2 conditions2 sponsors1 location
NCT03491046
Molecular Imaging Assessment of ACL Viability
NAActive, not recruiting
66 participants
Started: Oct 9, 2013 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT01941641
Colon Neoadjuvant FOLFOXIRI Study
PHASE2Active, not recruiting
40 participants
Started: Oct 9, 2013 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT01815749
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma
PHASE1Active, not recruiting
30 participants
Started: Oct 8, 2013 · Completed: Jun 1, 2026
24 conditions2 sponsors1 location
NCT01797523
A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma
PHASE2Active, not recruiting
62 participants
Started: Oct 7, 2013 · Completed: Oct 31, 2025
1 condition3 sponsors6 locations
NCT01937780
Anal Cancer Radiotherapy Study
N/AActive, not recruiting
75 participants
Started: Oct 4, 2013 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03226808
Vivacit-E Post-market Follow-up Study
NAActive, not recruiting
258 participants
Started: Oct 1, 2013 · Completed: Jun 30, 2028
4 conditions1 sponsor5 locations
NCT01918527
Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
PHASE3Active, not recruiting
250 participants
Started: Sep 30, 2013 · Completed: Dec 31, 2025
1 condition1 sponsor9 locations
NCT03084445
Impact of Exposure to Environmental Pollutants on Birth Outcomes in an Israeli Cohort
N/AActive, not recruiting
2,394 participants
Started: Sep 30, 2013 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT01992432
Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)
N/AActive, not recruiting
49 participants
Started: Sep 30, 2013 · Completed: Dec 12, 2025
1 condition2 sponsors2 locations
NCT01984710
Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S
NAActive, not recruiting
10 participants
Started: Sep 30, 2013 · Completed: Jan 31, 2029
1 condition4 sponsors1 location
NCT02221999
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
PHASE2/PHASE3Active, not recruiting
250 participants
Started: Sep 30, 2013 · Completed: Jan 31, 2029
4 conditions1 sponsor12 locations
NCT01984138
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy
PHASE2Active, not recruiting
44 participants
Started: Sep 30, 2013 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT01996046
FDG PET/CT in Breast Cancer Bone Mets
N/AActive, not recruiting
75 participants
Started: Sep 30, 2013 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT01947023
Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery
PHASE1Active, not recruiting
21 participants
Started: Sep 27, 2013 · Completed: Jun 1, 2026
2 conditions1 sponsor1 location
NCT01933932
Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC
PHASE3Active, not recruiting
510 participants
Started: Sep 25, 2013 · Completed: Dec 31, 2025
1 condition1 sponsor197 locations
NCT01955499
Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
PHASE1Active, not recruiting
39 participants
Started: Sep 24, 2013 · Completed: May 6, 2026
10 conditions1 sponsor3 locations
NCT01841736
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
PHASE2Active, not recruiting
171 participants
Started: Sep 20, 2013 · Completed: Sep 10, 2026
8 conditions1 sponsor426 locations
NCT01674140
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
PHASE3Active, not recruiting
1,939 participants
Started: Sep 12, 2013 · Completed: Jan 31, 2030
1 condition2 sponsors1459 locations
NCT02065011
A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B
PHASE2Active, not recruiting
9 participants
Started: Sep 12, 2013 · Completed: Jun 13, 2031
1 condition1 sponsor2 locations
NCT06876402
Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)
N/AActive, not recruiting
367 participants
Started: Sep 9, 2013 · Completed: May 15, 2025
1 condition1 sponsor1 location
NCT02874885
Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer
N/AActive, not recruiting
341 participants
Started: Sep 5, 2013 · Completed: Apr 30, 2027
13 conditions1 sponsor1 location
NCT01874353
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
PHASE3Active, not recruiting
327 participants
Started: Sep 3, 2013 · Completed: Dec 31, 2025
4 conditions4 sponsors126 locations
NCT02452580
The Norwegian Family Centered Care Study
N/AActive, not recruiting
77 participants
Started: Sep 1, 2013 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT01652209
To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.
PHASE3Active, not recruiting
90 participants
Started: Sep 1, 2013 · Completed: Oct 31, 2024
1 condition1 sponsor10 locations
NCT01911013
A Study of Korean Society of Spine Surgery on the Outcomes of Anterior Cervical Discectomy and Fusion
NAActive, not recruiting
500 participants
Started: Sep 1, 2013 · Completed: Sep 1, 2025
2 conditions2 sponsors31 locations
NCT03466541
Workplace Interventions Preventing Risky Use of Alcohol and Sick Leave
NAActive, not recruiting
500 participants
Started: Aug 31, 2013 · Completed: Dec 31, 2025
4 conditions8 sponsors1 location
NCT01872975
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
NAActive, not recruiting
1,636 participants
Started: Aug 31, 2013 · Completed: Aug 31, 2028
2 conditions3 sponsors514 locations
NCT01961232
Trans-pulmonary Biomarkers in Pulmonary Hypertension
N/AActive, not recruiting
100 participants
Started: Aug 31, 2013 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT01906814
Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation
PHASE3Active, not recruiting
179 participants
Started: Aug 31, 2013 · Completed: Apr 30, 2024
1 condition2 sponsors1 location
NCT01796197
Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa
PHASE2Active, not recruiting
23 participants
Started: Aug 31, 2013 · Completed: Nov 30, 2025
1 condition1 sponsor3 locations
NCT02004834
Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivacaine
PHASE4Active, not recruiting
80 participants
Started: Aug 31, 2013 · Completed: Oct 31, 2028
3 conditions1 sponsor1 location
NCT01994252
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
NAActive, not recruiting
200 participants
Started: Aug 31, 2013 · Completed: Sep 30, 2024
3 conditions2 sponsors15 locations
NCT03705897
PROSPR Project 1: Identifying and Tracking Personalized CRC Screening Regimens for Patients in Clinical Settings
NAActive, not recruiting
9,865 participants
Started: Aug 31, 2013 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05361473
Evaluation of a PCM Mattress to Treat HIE Infants During Transport
NAActive, not recruiting
140 participants
Started: Aug 31, 2013 · Completed: Mar 1, 2025
1 condition3 sponsors1 location
NCT03738553
Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy
N/AActive, not recruiting
13 participants
Started: Aug 31, 2013 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT01822652
3rd Generation GD-2 Chimeric Antigen Receptor and ICaspase Suicide Safety Switch, Neuroblastoma, GRAIN
PHASE1Active, not recruiting
11 participants
Started: Aug 31, 2013 · Completed: Oct 31, 2030
1 condition7 sponsors2 locations
NCT01957332
IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer
NAActive, not recruiting
217 participants
Started: Aug 30, 2013 · Completed: Oct 31, 2027
1 condition3 sponsors3 locations
NCT01953159
Assessment of Paclitaxel-Induced Neuropathy
N/AActive, not recruiting
43 participants
Started: Aug 29, 2013 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT01897480
A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations
PHASE2Active, not recruiting
150 participants
Started: Aug 28, 2013 · Completed: Dec 31, 2025
1 condition1 sponsor45 locations
NCT01856192
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
PHASE2Active, not recruiting
349 participants
Started: Aug 27, 2013 · Completed: Dec 31, 2025
3 conditions1 sponsor504 locations
NCT01844986
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
PHASE3Active, not recruiting
450 participants
Started: Aug 26, 2013 · Completed: Aug 29, 2028
7 conditions4 sponsors177 locations
NCT01893307
Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer
PHASE3Active, not recruiting
440 participants
Started: Aug 26, 2013 · Completed: Dec 31, 2031
3 conditions3 sponsors22 locations